Innovotech Inc. is a Canada-based company, which provides practical services and solutions for dealing with medical, agricultural and industrial problems caused by microbial biofilms. The Company is engaged in the sales of its products, conducting contract research for outside customers and research and development to identify products for future commercialization. The Company's products include human and veterinary biofilm susceptibility tests, a seed treatment designed to combat both bacterial and fungal diseases, and an assay used in growing microbial biofilms for research purposes. Its contract research specializes in solving biofilm issues and assembles data packages for regulatory applications required by the United States Food and Drug Administration (FDA) and other regulatory bodies for implant medical devices. Its lead product, InnovoSIL-1, has completed the proof-of-concept phase that demonstrated that InnovoSIL-1 eliminates microorganism.